$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Coronavirus update: U.S. death toll tops 115,000 amid growing worry about uptick in cases in Florida, Texas among others
03:41pm, Monday, 15'th Jun 2020
The U.S. death toll from the coronavirus illness COVID-19 climbed above 115,000 on Monday, and the stock market tanked amid growing concerns about the uptick...
Lilly Is Testing Its Arthritis Drug as a Coronavirus Treatment
12:40pm, Monday, 15'th Jun 2020
The company said it is sponsoring a 400-patient randomized trial to confirm whether the drug Olumiant can moderate Covid symptoms.
Incyte Launches New Global Responsibility Section on Incyte.com
12:00pm, Monday, 15'th Jun 2020
Incyte Launches New Global Responsibility Section on Incyte.com
Lilly's shares drop as it enrolls first patient in COVID-19 study for arthritis drug
11:36am, Monday, 15'th Jun 2020
Shares of Eli Lilly & Co. undefined were down 1.1% in premarket trading on Monday after the drugmaker said the first patient had been enrolled in a...
Lilly's shares drop as it enrolls first patient in COVID-19 study for arthritis drug
11:36am, Monday, 15'th Jun 2020
Shares of Eli Lilly & Co. were down 1.1% in premarket trading on Monday after the drugmaker said the first patient had been enrolled in a late-stage trial assessing rheumatoid arthritis drug Olumiant
Before Spreadsheets, Tape Held Together A Handwritten Chart Discovering The Genetic Code
11:29am, Monday, 15'th Jun 2020
The chart filled in by biochemists and preserved by the U.S. National Library of Medicine shows how complicated it was to figure out the universal code behind the cells of living organisms. Other …
Eli Lilly and : Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients | MarketScreener
10:46am, Monday, 15'th Jun 2020Incyte Launches New Global Responsibility Section on Incyte.com
12:00am, Monday, 15'th Jun 2020
Incyte Launches New Global Responsibility Section on Incyte.com
As efficacy of Constellation's cancer drug wanes, debate over data grows
06:31pm, Friday, 12'th Jun 2020
Whether the latest data on the experimental drug for myelofibrosis patients is good or bad news depends on your point of view.
Lonza décroche un contrat auprès d'Anthos Therapeutics | Zone bourse
05:31am, Thursday, 11'th Jun 2020Global Leukemia Therapeutics Market Forecast and Opportunities to 2025 - ResearchAndMarkets.com
12:00am, Thursday, 11'th Jun 2020
The
Small Caps Build Steam And Biotechs Remain Well-Positioned
02:15pm, Wednesday, 10'th Jun 2020
Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re
Lonza s'associe les services du suédois Cellink dans la bio-impression en 3D | Zone bourse
01:20pm, Wednesday, 10'th Jun 2020Here's the Surprising Coronavirus Stock You'll Really Want to Watch Right Now | The Motley Fool
11:01am, Wednesday, 10'th Jun 2020
It's a 144-year-old big pharma...but it's quickly become the leader in a key area of fighting COVID-19.
Sign In
Buy INCY